SACCATOSIDE
UNII RJ46GBS6PY

Substance Identification & Data

This profile provides standardized clinical and technical data for Saccatoside, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RJ46GBS6PY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 85819-35-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RJ46GBS6PY

CAS Registry Number

85819-35-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SACCATOSIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C30H38O16

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XIPQZLUSSJDAIC-UYESFEPRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

15736668

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)[C@H]2[C@]3([C@@](C=CO2)([C@@H]([C@]4([C@@]3(O4)CO)[H])O[C@H]5[C@H](OC(/C=C/c6ccc(cc6)O)=O)[C@H](O)[C@@H](O)[C@@H](O5)C)[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Saccatoside. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

6-O-.ALPHA.-L-(2-O-TRANS-P-COUMAROYL)RHAMNOPYRANOSYLCATALPOL

SACCATOSIDE

Systematic Nomenclature

(2S,3R,4R,5R,6S)-4,5-DIHYDROXY-2-(((1S,2S,4S,5S,6R,10S)-2-(HYDROXYMETHYL)-10-(((2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY)-3,9-DIOXATRICYCLO(4.4.0.0^(2,4))DEC-7-EN-5-YL)OXY)-6-METHYLOXAN-3-YL (2E)-3-(4-HYDROXYPHENYL)PROP-2-ENOATE

SYS

.BETA.-D-GLUCOPYRANOSIDE, (1AS,1BS,2S,5AR,6S,6AS)-6-((6-DEOXY-2-O-((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)-.ALPHA.-L-MANNOPYRANOSYL)OXY)-1A,1B,2,5A,6,6A-HEXAHYDRO-1A-(HYDROXYMETHYL)OXIRENO(4,5)CYCLOPENTA(1,2-C)PYRAN-2-YL

SYS

.BETA.-D-GLUCOPYRANOSIDE, (1AS,1BS,2S,5AR,6S,6AS)-6-((6-DEOXY-2-O-((2E)-3-(4-HYDROXYPHENYL)-1-OXO-2-PROPENYL)-.ALPHA.-L-MANNOPYRANOSYL)OXY)-1A,1B,2,5A,6,6A-HEXAHYDRO-1A-(HYDROXYMETHYL)OXIRENO(4,5)CYCLOPENTA(1,2-C)PYRAN-2-YL

SYS

.BETA.-D-GLUCOPYRANOSIDE, 6-((6-DEOXY-2-O-(3-(4-HYDROXYPHENYL)-1-OXO-2-PROPENYL)-.ALPHA.-L-MANNOPYRANOSYL)OXY)-1A,1B,2,5A,6,6A-HEXAHYDRO-1A-(HYDROXYMETHYL)OXIRENO(4,5)CYCLOPENTA(1,2-C)PYRAN-2-YL, (1AS-(1A.ALPHA.,1B.BETA.,2.BETA.,5A.BETA.,6.BETA.,6A.ALPHA.))-

SYS

External Clinical & Regulatory Resources

Previous UNIIRJ43YZA8UQ

Next UNIIRJ4J4UMV5H